#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


Accelerator Meeting Point 2024: Bridging Borders in innovation

Bridging borders in innovation Vine a la nova edició de l’#AMP2024, el lloc on saber més sobre…

Read More

Bedside to Bench to Curbside: Addressing Breast Cancer Health Disparities

#IDIBELLextraordinaryseminar I will present – 1. aspects of cancer health disparities related to aggressive and rare breast…

Read More

Atypical Eating Disorders (OSFED): Clinical Features, Diagnostic entity and Treatment

Conferència: Atypical Eating Disorders (OSFED): Clinical Features, Diagnostic entity and Treatment Dra. Isabel Krug Associate Professor of…

Read More

Malaltia, Cervell… i medi ambient? EL CAS I RECERCA SOBRE L’ELA

PESSICS DE CIÈNCIA. SETMANA MUNDIAL DEL CERVELL 2024 Conferència a càrrec de Mónica Povedano. Metge del servei…

Read More

#IDIBELLseminars: Novel Therapeutic Targets in T-cell Leukemia

We recently identified a therapeutically exploitable NOTCH1-SIRT1-KAT7 axis in T-ALL, suggesting that directly targeting KAT7 might be…

Read More

Thesis: Deciphering pathomechanisms underlying genetic lipid disorders of the brain

15 de Març, Sala Pau Viladiu, a les 11.00 Tesi: Deciphering pathomechanisms underlying genetic lipid disorders of…

Read More

I Jornada de Malalties Autoimmunes

Àrea d’influència de l’Hospital de Viladecans Coordinació: Dra. Ana Ponce, Adjunta del Servei de Medicina Interna de…

Read More

#IDIBELLseminars: Uterine leiomyoma as a model for neoplasia

Uterine leiomyomas (ULs) are benign yet neoplastic tumors of the uterine smooth muscle wall. They are remarkably…

Read More

I Jornada d’Innovació sobre el Diagnòstic i Tractament dels Pacients amb Càncer de Pulmó

Adreçat a personal mèdic i d’infermeria implicat en el maneig de pacients amb càncer de pulmó de…

Read More

#IDIBELLseminars: Brain Structural Plasticity and Wiring in Mental Illness

Fragile X syndrome (FXS), a neurodevelopmental disorder, arises due to malfunctions in the RNA binding protein FMRP,…

Read More
Scroll to Top